| Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587) |
|---|
| 01/05/2012 | WO2011094545A3 Compositions and methods for enhancing proteasome activity |
| 01/05/2012 | US20120004423 Synthesis of obtaining modified polyethylene glycol intermediates |
| 01/05/2012 | US20120004224 Triheterocyclic Compounds and Compositions Thereof |
| 01/05/2012 | US20120004217 Therapeutic agents useful for treating pain |
| 01/05/2012 | US20120004210 Substituted quinazoline compounds |
| 01/05/2012 | US20120004207 Therapeutic uses of derivatives of piperidinyl-and piperidinyl-alkyl carbamates |
| 01/05/2012 | US20120004196 Anti-Viral Compounds |
| 01/05/2012 | US20120003229 Modulators of cytokine mediated signalling pathways and integrin alphavbeta3 receptor antagonists for combination therapy |
| 01/05/2012 | US20120003213 Methods Of Enhancing Antibody-Dependent Cellular Cytotoxicity |
| 01/05/2012 | CA2804347A1 Heterocyclic alkynyl benzene compounds and medical compositions and uses thereof |
| 01/05/2012 | CA2804225A1 Heterocyclic compound and p27kip1 degradation inhibitor |
| 01/05/2012 | CA2803879A1 Compositions and methods for modulating the wnt signaling pathway |
| 01/05/2012 | CA2803752A1 6-acyl-1,2,4-triazine-3,5-dione derivative and herbicides |
| 01/05/2012 | CA2802380A1 3-amino-5,6-dihydro-1h-pyrazin-2-one derivatives useful for the treatment of alzheimer's disease and other forms of dementia |
| 01/05/2012 | CA2801814A1 Quinazoline compounds |
| 01/04/2012 | EP2402351A1 Pyrromethene-boron complex compounds and organic electro- luminescent elements using same |
| 01/04/2012 | EP2402334A1 Inhibitors of E1 Activating Enzymes |
| 01/04/2012 | EP2402331A1 Inhibitors of serine proteases |
| 01/04/2012 | EP2402329A1 Analgetic phenylsulphonamides |
| 01/04/2012 | EP2402325A2 Hydroxylated and methoxylated cyclopenta[d]pyrimidines as AKT protein kinase inhibitors |
| 01/04/2012 | EP2402009A1 Inhibitors of serine protease, particularly hepatitis c virus NS3-NS4A protease, incorporating a fused ring system |
| 01/04/2012 | EP2401269A1 Indole derivatives as crth2 receptor antagonists |
| 01/04/2012 | EP2401267A1 Jak kinase modulating quinazoline derivatives and methods of use thereof |
| 01/04/2012 | EP2401266A1 Novel dioxo-imidazolidine derivatives, which inhibit the enzyme soat-1, pharmaceutical and cosmetic compositions containing them |
| 01/04/2012 | EP2401254A1 Quinone compounds as dopants in organic electronics |
| 01/04/2012 | EP2400846A1 Hepatitis c virus inhibitors |
| 01/04/2012 | EP2297103B1 Hydroxyphenylsulfonamides as antiapoptotic bcl inhibitors |
| 01/04/2012 | EP2265582B1 Novel 3-aminoalkyl-1,3-dihydro-2h-indol-2-one derivatives, preparation thereof and therapeutic use thereof. |
| 01/04/2012 | EP2049502B1 2,4-substituted quinazolines as lipid kinase inhibitors |
| 01/04/2012 | EP1957482B1 Quinazolines useful as modulators of voltage gated ion channels |
| 01/04/2012 | EP1735286B1 Tetrahydro-indazole cannabinoid modulators |
| 01/04/2012 | EP1441720B1 Inhibitors of serine protease, particularly hepatitis c virus ns3-ns4a protease, incorporating a fused ring system |
| 01/04/2012 | CN102307871A Isoindolinone and related analogs as sirtuin modulators |
| 01/04/2012 | CN102307870A Pyridyloxyindoles inhibitors of VEGF-R2 and use thereof for treatment of disease |
| 01/04/2012 | CN102307869A Aminopyrazine derivative and medicine |
| 01/04/2012 | CN102307853A Pyrrolidine derivatives as NK3 receptor antagonists |
| 01/04/2012 | CN102307852A Cyclic amine compounds |
| 01/04/2012 | CN102307622A Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases |
| 01/04/2012 | CN102304108A Five-membered heterocyclic dicarbonyl derivative and application thereof on multi-drug resistant bacteria |
| 01/04/2012 | CN101875636B Imidazoline-2,4-diketone derivative and preparation method and applications thereof |
| 01/04/2012 | CN101665463B Phenyl dual-imidazole compounds, synthesis method and application thereof |
| 01/04/2012 | CN101528708B Indazole derivatives useful as l-cpt1 inhibitors |
| 01/04/2012 | CN101289444B Pyrimidine derivate and medicinal use thereof |
| 01/04/2012 | CN101155783B Pyrazoles |
| 01/03/2012 | US8088925 Heteroaryl-carboxylic acid (sulfamoyl alkyl) amide-derivatives as factor Xa inhibitors |
| 01/03/2012 | US8088924 Pyridone derivatives having a binding activity to the cannabinoid type 2 receptor |
| 01/03/2012 | US8088816 3-3-di-substituted-oxindoles as inhibitors of translation initiation |
| 01/03/2012 | US8088808 Substituted N-phenyl-bipyrrolidine carboxamides and therapeutic use thereof |
| 01/03/2012 | US8088784 4-(3-aminopyrazole) pyrimidine derivatives for use as tyrosine kinase inhibitors in the treatment of cancer |
| 01/03/2012 | US8088776 Biphenyl amide lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
| 01/03/2012 | US8088774 Anti-inflammatory and protein kinase inhibitor compositions and related methods for downregulation of detrimental cellular responses and inhibition of cell death |
| 01/03/2012 | US8088769 e.g. 2-(3,4-Dichlorophenyl)ethanamidine hydrochloride; phosphodiesterases inhibitor; learning enhancement, cognition activator; improving perception, concentration, or memory |
| 01/03/2012 | US8088768 Protein kinase and phosphatase inhibitors |
| 01/03/2012 | US8088767 JAK-2 modulators and methods of use |
| 01/03/2012 | US8088766 Cyanoguanidines and cyanoamidines as ErbB2 and EGFR inhibitors |
| 01/03/2012 | US8088368 Antiviral compounds |
| 01/03/2012 | CA2662148C Phthalazine, aza- and diaza-phthalazine compounds and medicinal uses thereof |
| 01/03/2012 | CA2632194C N4-phenyl-quinazoline-4-amine derivatives and related compounds as erbb type i receptor tyrosine kinase inhibitors for the treatment of hyperproliferative diseases |
| 01/03/2012 | CA2545311C Heterocyclic boronic acid compounds |
| 01/03/2012 | CA2515132C Heteroaryl substituted pyrroles useful as inhibitors of protein kinases |
| 01/03/2012 | CA2489128C 2-ureido-6-heteroaryl-3h-benzoimidazole-4-carboxylic acid derivatives and related compounds as gyrase and/or topoisomerase iv inhibitors for the treatment of bacterial infections |
| 01/03/2012 | CA2480356C Benzamide derivatives useful as histone deacetylase inhibitors |
| 12/29/2011 | WO2011162190A1 Metal complexes of squarylium compounds and optical recording media comprising same |
| 12/29/2011 | WO2011162162A1 Light-emitting device material and light-emitting device |
| 12/29/2011 | WO2011161945A1 Alkoxyimino derivative and pest control agent |
| 12/29/2011 | WO2011161615A1 5-lipoxygenase inhibitors |
| 12/29/2011 | WO2011160758A1 Materials for organic electroluminescent devices |
| 12/29/2011 | WO2011160569A1 Pyrazolyl quinazolone compounds and uses thereof |
| 12/29/2011 | WO2011139414A3 Dexlansoprazole polymorphic forms |
| 12/29/2011 | WO2011103524A3 Cyclic tetrapeptides and therapeutic applications thereof |
| 12/29/2011 | WO2011084796A3 Novel quinazoline derivatives |
| 12/29/2011 | WO2011041634A8 Pyrazole inhibitors of phosphatidylinositol 3-kinase |
| 12/29/2011 | WO2010107809A3 Methods for preparing dpp-iv inhibitor compounds |
| 12/29/2011 | US20110319620 Method for producing carboxylic anhydride and arylboronic acid compound |
| 12/29/2011 | US20110319614 Organic Compounds |
| 12/29/2011 | US20110319610 Diazepinedione derivative |
| 12/29/2011 | US20110319516 Release agent partition control in imprint lithography |
| 12/29/2011 | US20110319460 Kinase inhibitors |
| 12/29/2011 | US20110319448 Guanidine-containing compounds useful as muscarinic receptor antagonists |
| 12/29/2011 | US20110319447 Triazole compounds that modulate hsp90 activity |
| 12/29/2011 | US20110319436 Methods and Compositions for Modulating IRE1, SRC, and ABL Activity |
| 12/29/2011 | US20110319430 Fungicidal pyrazoles |
| 12/29/2011 | US20110319420 Preparation method of dihydroindene amide compounds, their pharmaceutical compositions containing compounds thereof and use as protein kinases inhibitor |
| 12/29/2011 | US20110319418 Prokineticin 1 receptor antagonists for the treatment of pain |
| 12/29/2011 | US20110319414 Novel triazine derivative and pharmaceutical composition comprising the same |
| 12/29/2011 | US20110319413 Piperazine compound capable of inhibiting prostaglandin d synthase |
| 12/29/2011 | US20110319411 Isoindolinone and related analogs as sirtuin modulators |
| 12/29/2011 | US20110319400 Prokineticin 1 receptor antagonists for the treatment of pain |
| 12/29/2011 | US20110319398 Inhibition of yops translocation |
| 12/29/2011 | US20110319396 Benzodiazepin-2-on derivatives |
| 12/29/2011 | US20110319393 Anthelmintic agents and their use |
| 12/29/2011 | US20110319385 Quinoxaline compound |
| 12/29/2011 | US20110319379 Substituted Indazole Amides And Their Use As Glucokinase Activators |
| 12/29/2011 | US20110318393 Substituted Pyrazole Compounds |
| 12/29/2011 | US20110318345 Nasal delivery |
| 12/29/2011 | US20110318280 Polymeric anti-microbial agents |
| 12/29/2011 | DE102010024897A1 Materialien für organische Elektrolumineszenzvorrichtungen Materials for organic electroluminescent |
| 12/28/2011 | EP2399909A1 Hydroxylated and methoxylated cyclopenta[d]pyrimidines as akt protein kinase inhibitors |
| 12/28/2011 | EP2398796A1 Heterocyclic derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
| 12/28/2011 | EP2398795A1 Heteroaryl substituted pyridazinone derivatives |